April 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJuly 24, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJuly 09, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJune 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreApril 21, 2026
Projections indicate that, the global cell & gene therapy (CGT) biomanufacturing market will increase from USD 14.03 billion in 2024 to USD 41.41 billion by 2034, experiencing a CAGR of 11.43% over the next 10 years. Increasing outsourcing & contract manufacturing have driven the growth of the market. North America led the global market owi...
April 21, 2026
According to market projections, the global gene overexpression cell line construction market, valued at USD 788.63 million in 2024, is anticipated to reach USD 1,629.93 million by 2034, growing at a CAGR of 7.53% over the next decade. The versatility of an overexpression research tool makes it popular among wild-type and mutant research. North Ame...
April 21, 2026
Projections indicate that, cell and gene therapy CRO industry is projected to rise from USD 4.90 billion in 2024 to USD 12.59 billion by 2034, reflecting a CAGR of 9.9% over the next decade. The cell and gene therapy CRO market is growing as CROs work with cell and gene therapies targeting a wide array of diseases, cancer, rare and inherited geneti...
April 21, 2026
According to Rohan Patil, who specializes in advanced therapies, pharmaceuticals, and healthcare services with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the cell and gene therapy cold chain logistics market. The cell and gene therapy cold chain logistics market size ...
April 21, 2026
Market insights predict, the cell and gene therapy (CGT) pharmaceuticals industry is expected to grow from USD 16.75 billion in 2024 to USD 91.56 billion by 2034, driven by a CAGR of 18.93%. The growing demand for personalized medicine, driving patient-specific therapies, is estimated to drive the growth of the market. North America led the global ...
April 21, 2026
Based on market forecasts, the global cell and gene therapy manufacturing QC market, projected at USD 2.66 billion in 2024, is expected to reach USD 12.35 billion by 2034, growing at a CAGR of 16.89% over the forecast period. The growing demand for cell and gene therapy and stringent regulatory policies drive the global market. North America domina...
April 21, 2026
According to forecasts, the global cell and gene therapy bioassay services market will grow from USD 5.05 billion in 2024 to USD 16 billion by 2034, with an expected CAGR of 12.24%. A rise in personalized trends is expanding the global market development. North America dominated the market due to the growing focus on the growth of specialized bioan...
April 21, 2026
Market insights predict the global orthopedic 3D printing devices industry will increase from USD 1.28 billion in 2024 to USD 6.87 billion by 2034, achieving a CAGR of 11.24%. The market is growing due to rising demand for personalized implants, faster prototyping, and cost-effective surgical solutions. North America is dominating the market due to...
April 21, 2026
According to market projections, the viral vector-based cell & gene therapy CDMO sector is expected to grow from USD 142.77 million in 2024 to USD 497.7 million by 2034, reflecting a CAGR of 13.44%. The key benefits of collaborating with a viral vector CDMO including therapeutic development and clinical trials drive the expansion of these organ...
April 21, 2026
According to market projections, the global oncology API market, valued at USD 41.79 billion in 2024, is anticipated to reach USD 69.55 billion by 2034, growing at a CAGR of 5.24% over the next decade. The rising prevalence of cancer and the growing demand for personalized medicines bolster market growth. The availability of state-of-the-art resear...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
